Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion

Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]Logos of Gilead at the company's booth at the 8th China International Import Expo (CIIE) in Shanghai, China, November 6, 2025.REUTERS/Maxim Shemetov [Purchase Licensing Rights, opens new tab]- Companies[Arcellx Inc]Follow[Gilead Sciences Inc]FollowFeb 23 (Reuters) - Gilead Sciences will pay as much as $7.8 billi ...